---
title: "Vivos Therapeutics extends Streeterville deal to convert up to $4.5 million debt into equity"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290436375.md"
description: "Vivos Therapeutics extended its strategic financing agreement with Streeterville Capital until August 31, 2026. Streeterville plans to convert up to $4.5 million of debt into preferred and common stock once Vivos raises $2.6 million. This extension supports equity strength and Nasdaq listing compliance."
datetime: "2026-06-22T12:30:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290436375.md)
  - [en](https://longbridge.com/en/news/290436375.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290436375.md)
---

# Vivos Therapeutics extends Streeterville deal to convert up to $4.5 million debt into equity

-   Vivos Therapeutics extended its strategic financing agreement with Streeterville Capital through Aug. 31, 2026. \* Streeterville reaffirmed plans to convert up to USD 4.5 million of debt into perpetual, non-convertible preferred stock, common stock. \* Conversion starts once Vivos raises USD 2.6 million, continuing up to the USD 4.5 million cap. \* Extension gives more time for an equity raise, supporting stockholders’ equity strength, Nasdaq continued listing compliance. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606220830PRIMZONEFULLFEED9750334) on June 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [VVOS.US](https://longbridge.com/en/quote/VVOS.US.md)

## Related News & Research

- [Vivos President Brad Weeks acquires $4,600 of common shares](https://longbridge.com/en/news/293512872.md)
- [Vivos Therapeutics extends Streeterville debt-to-equity conversion deal through Aug. 31, 2026](https://longbridge.com/en/news/290882086.md)
- [TMV: Enterprise momentum, AI adoption, and ServiceNow partnership drive confidence in H2 growth](https://longbridge.com/en/news/294041002.md)
- [CapMan to release half-year report for January-June 2026 period](https://longbridge.com/en/news/294309506.md)
- [Raisio to release half-year financial report for January-June 2026](https://longbridge.com/en/news/294178561.md)